Literature DB >> 21804617

IL-17A in LCH: systemic biomarker, local factor, or none of the above?

Michael D Hogarty1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21804617      PMCID： PMC3149169          DOI： 10.1038/mt.2011.150

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  4 in total

1.  Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Authors:  Tricia L Peters; Kenneth L McClain; Carl E Allen
Journal:  Mol Ther       Date:  2011-06-07       Impact factor: 11.454

2.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

3.  Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion.

Authors:  Fabienne Coury; Nicola Annels; Aymeric Rivollier; Selma Olsson; Alessandra Santoro; Carole Speziani; Olga Azocar; Monique Flacher; Sophia Djebali; Jacques Tebib; Maria Brytting; R Maarten Egeler; Chantal Rabourdin-Combe; Jan-Inge Henter; Maurizio Arico; Christine Delprat
Journal:  Nat Med       Date:  2007-12-23       Impact factor: 53.440

4.  Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions.

Authors:  Carl E Allen; Kenneth L McClain
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440
  4 in total
  5 in total

1.  Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?

Authors:  Polyzois Makras; Stergios A Polyzos; Athanasios D Anastasilakis; Evangelos Terpos; Athanasios Papatheodorou; Gregory A Kaltsas
Journal:  Mol Ther       Date:  2012-01       Impact factor: 11.454

2.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

3.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

Review 4.  Merkel cell polyomavirus and Langerhans cell neoplasm.

Authors:  Ichiro Murakami; Noriko Wada; Junko Nakashima; Mitsuko Iguchi; Makoto Toi; Yumiko Hashida; Tomonori Higuchi; Masanori Daibata; Michiko Matsushita; Takeshi Iwasaki; Satoshi Kuwamoto; Yasushi Horie; Keiko Nagata; Kazuhiko Hayashi; Takashi Oka; Tadashi Yoshino; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Jean Gogusev; Francis Jaubert
Journal:  Cell Commun Signal       Date:  2018-08-22       Impact factor: 5.712

Review 5.  Bone metabolism in Langerhans cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Marina Tsoli; Gregory Kaltsas; Polyzois Makras
Journal:  Endocr Connect       Date:  2018-07-02       Impact factor: 3.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.